Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Phreesia, Inc.
Phreesia, Inc. News
Phreesia, Inc. Quantitative Score
About Phreesia, Inc.
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.
Phreesia, Inc. Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Phreesia, Inc. Financials
Table Compare
Compare PHR metrics with: | |||
|---|---|---|---|
Earnings & Growth | PHR | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | PHR | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | PHR | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | PHR | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Phreesia, Inc. Income
Phreesia, Inc. Balance Sheet
Phreesia, Inc. Cash Flow
Phreesia, Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Buy |
| Return on Equity | Strong Sell |
| Return on Assets | Strong Sell |
| Debt/Equity Ratio | Neutral |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Historical Market Cap
Shares Outstanding
Phreesia, Inc. Executives
| Name | Role |
|---|---|
| Mr. David Linetsky | President of Network Solutions |
| Mr. Chaim Indig | Co-Founder, Chief Executive Officer & Director |
| Mr. Evan Roberts | Co-Founder & President of Provider Solutions |
| Mr. Balaji Gandhi | Chief Financial Officer |
| Ms. Allison C. Hoffman J.D. | General Counsel & Secretary |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. David Linetsky | President of Network Solutions | Male | 1980 | 597.34K |
| Mr. Chaim Indig | Co-Founder, Chief Executive Officer & Director | Male | 1979 | 515K |
| Mr. Evan Roberts | Co-Founder & President of Provider Solutions | Male | 1979 | 400K |
| Mr. Balaji Gandhi | Chief Financial Officer | Male | 1975 | 400K |
| Ms. Allison C. Hoffman J.D. | General Counsel & Secretary | Female | 1971 | 350K |
Phreesia, Inc. Insider Trades
| Date | 31 Oct |
| Name | Goldstein Lainie |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 441 |
| Date | 31 Oct |
| Name | Munson Gillian |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 441 |
| Date | 31 Oct |
| Name | CAHILL EDWARD L |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 441 |
| Date | 17 Oct |
| Name | Gandhi Balaji |
| Role | Chief Financial Officer |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 885 |
| Date | 17 Oct |
| Name | Hoffman Allison C |
| Role | General Counsel & Secretary |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 1241 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 31 Oct | Goldstein Lainie | Director | Acquired | A-Award | 441 |
| 31 Oct | Munson Gillian | Director | Acquired | A-Award | 441 |
| 31 Oct | CAHILL EDWARD L | Director | Acquired | A-Award | 441 |
| 17 Oct | Gandhi Balaji | Chief Financial Officer | Disposed | S-Sale | 885 |
| 17 Oct | Hoffman Allison C | General Counsel & Secretary | Disposed | S-Sale | 1241 |